You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK (GenomeWeb) – A team led by researchers at the University of Maryland and the National Cancer Institute has developed a gene expression-based predictor of response to immune checkpoint blockade therapy in metastatic melanoma patients.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.